Percutaneous Interventions in Patients With Immune-Mediated Heparin-Induced Thrombocytopenia
The use of unfractionated heparin, the traditional antithrombotic agent during percutaneous coronary interventions (PCI), is associated with the risk of heparin-induced thrombocytopenia, […]